Cargando…
Case report of a KIT-mutated melanoma patient with an excellent response to apatinib and temozolomide combination therapy
Malignant melanoma is one kind of malignant disease which has high rates of mortality, metastasis, and poor prognosis. The therapeutic landscape is rapidly changing with the development of novel agents in recent decades, such as anti-PD-1 agents, anti-CTLA-4 agents, and BRAF inhibitors. However, sin...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604556/ https://www.ncbi.nlm.nih.gov/pubmed/29066909 http://dx.doi.org/10.2147/OTT.S146409 |